Free Trial

Oribel Capital Management LP Invests $26.74 Million in CME Group Inc. $CME

CME Group logo with Finance background

Key Points

  • Oribel Capital Management LP has acquired a new stake in CME Group Inc., purchasing 100,800 shares valued at approximately $26.74 million, which represents 1.1% of its holdings.
  • The company recently reported $2.96 EPS for its latest quarter, exceeding analysts' expectations, with revenue increasing by 10.4% year-over-year.
  • CME Group declared a quarterly dividend of $1.25, with an annualized dividend yield of 1.9%, scheduled for payment to investors of record on September 9th.
  • Looking to export and analyze CME Group data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Oribel Capital Management LP acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 100,800 shares of the financial services provider's stock, valued at approximately $26,741,000. CME Group makes up approximately 1.1% of Oribel Capital Management LP's portfolio, making the stock its 13th biggest position.

A number of other hedge funds have also added to or reduced their stakes in the stock. Heartland Bank & Trust Co purchased a new position in CME Group during the first quarter worth about $377,000. Catalyst Capital Advisors LLC raised its stake in shares of CME Group by 256.9% in the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after buying an additional 2,636 shares during the period. OMNI 360 Wealth Inc. bought a new position in shares of CME Group during the 1st quarter worth $367,000. Fulcrum Equity Management purchased a new stake in CME Group in the 1st quarter worth about $258,000. Finally, AIA Group Ltd lifted its holdings in CME Group by 17.8% during the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock valued at $4,416,000 after purchasing an additional 2,510 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CME. UBS Group reissued a "neutral" rating and set a $305.00 target price on shares of CME Group in a report on Thursday, July 24th. Citigroup raised their target price on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. Oppenheimer increased their target price on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Finally, Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, CME Group has an average rating of "Hold" and a consensus price target of $261.93.

Read Our Latest Report on CME Group

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard bought 256 shares of the business's stock in a transaction dated Wednesday, June 25th. The shares were purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the completion of the purchase, the director owned 258,196 shares in the company, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

CME Group Stock Down 1.2%

CME traded down $3.35 on Thursday, hitting $266.77. The company had a trading volume of 1,753,190 shares, compared to its average volume of 2,319,193. The stock has a fifty day simple moving average of $275.89 and a 200-day simple moving average of $268.88. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $96.14 billion, a P/E ratio of 25.82, a P/E/G ratio of 4.92 and a beta of 0.44. CME Group Inc. has a 52-week low of $207.75 and a 52-week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same quarter last year, the business posted $2.56 EPS. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a $1.25 dividend. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group's dividend payout ratio is presently 48.40%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines